Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | AGXT | P21549 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | PPARG | P37231 | 2/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.50 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL17360618 | 0.91 | KDM4E (0.58) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL3266342 | 0.90 | KDM4E (0.66) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL16902851 | 0.87 | TDP1 (0.87) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL8565990 | 0.85 | TDP1 (0.76) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL1859481 | 0.85 | TDP1 (0.76) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL29429997 | 0.85 | TDP1 (0.76) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL6926963 | 0.83 | TDP1 (0.68) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL16902870 | 0.83 | TDP1 (0.73) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL3624437 | 0.83 | AGXT (0.63) | KDM4ETDP1MAPK1AGXTNPC1 | |
| SCHEMBL16902871 | 0.83 | TDP1 (0.73) | KDM4ETDP1MAPK1AGXTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9644280-B2 | Process for electrolytically depositing a tin- and ruthenium-based alloy, the electrolytic bath therefore and the alloy obtained therewith | VALMET PLATING S.R.L. (IT) | 2017-05-09 | — | — | US | claimed |
| US-20150354076-A1 | Process for Electrolytically Depositing a Tin- and Rutenium-Based Alloy, the Electrolytic Bath That Permits Said Alloy to Deposit and the Alloy Obtained by Means of Said Process | VALMET PLATING SRL (IT) | 2015-12-10 | — | — | US | claimed |
| EP-2757180-B1 | A process for electrolytically depositing a tin- and ruthenium-based alloy, the electrolytic bath that permits said alloy to deposit and the alloy obtained by means of said process | VALMET PLATING S R L (IT) | 2015-08-12 | — | — | EP | claimed |
| US-9005445-B2 | Method of testing integrity of microporous membrane | ASAHI KASEI MEDICAL CO., LTD. (JP) | 2015-04-14 | — | — | US | claimed |
| US-8927623-B2 | Recording ink, ink/media set, ink cartridge, inkjet recording method and inkjet recording apparatus | RICOH COMPANY, LTD. (JP) | 2015-01-06 | — | — | US | claimed |
| US-20140314702-A1 | COMPOSITION | CONOPCO, INC., D/B/A UNILEVER | 2014-10-23 | — | — | US | claimed |
| WO-2014111761-A1 | A PROCESS FOR ELECTROLYTICALLY DEPOSITING A TIN- AND RUTHENIUM-BASED ALLOY, THE ELECTROLYTIC BATH THAT PERMITS SAID ALLOY TO DEPOSIT AND THE ALLOY OBTAINED BY MEANS OF SAID PROCESS | VALMET S.P.A. (IT) | 2014-07-24 | — | — | WO | claimed |
| EP-2757180-A1 | A process for electrolytically depositing a tin- and ruthenium-based alloy, the electrolytic bath that permits said alloy to deposit and the alloy obtained by means of said process | Valmet S.p.A. (IT) | 2014-07-23 | — | — | EP | claimed |
| EP-2747841-A2 | HAIR CONDITIONING COMPOSITION COMPRISING A BLEND OF METAL PYRITHIONE WITH A NON-ANIONIC SURFACTANT AND FURTHER COMPRISING A SILICONE | Unilever N.V. (NL) | 2014-07-02 | — | — | EP | claimed |
| EP-2127787-B1 | METHOD FOR TEST ON INTEGRITY OF MICROPOROUS MEMBRANE | ASAHI KASEI MEDICAL CO LTD (JP) | 2013-05-08 | — | — | EP | claimed |
| EP-2054477-B1 | RECORDING INK, INK/MEDIA SET, INK CARTRIDGE, INKJET RECORDING METHOD AND INKJET RECORDING APPARATUS | RICOH CO LTD (JP) | 2013-05-01 | — | — | EP | claimed |
| WO-2013026728-A2 | COMPOSITION | UNILEVER N.V. (NL) | 2013-02-28 | — | — | WO | claimed |
| US-20100096328-A1 | METHOD OF TESTING INTEGRITY OF MICROPOROUS MEMBRANE | ASAHI KASEI MEDICAL CO., LTD. (JP) | 2010-04-22 | — | — | US | claimed |
| EP-2127787-A1 | METHOD FOR TEST ON INTEGRITY OF MICROPOROUS MEMBRANE | Asahi Kasei Medical Co., Ltd. (JP) | 2009-12-02 | — | — | EP | claimed |
| JP-9012958-A | — | — | None | — | — | JP | disclosed |
| US-12044971-B2 | Aqueous developer for flexographic printing plate and manufacturing method of flexographic printing plate | FUJIFILM CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| US-20240218197-A1 | RECORDING INK, INK SET, INK MEDIA SET, AND PRINTING MEDIA | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2024-07-04 | — | — | US | disclosed |
| US-5059514-A | Bleaching using promoter and subjecting waste liquid to anionic exchange resin | FUJI PHOTO FILM CO., LTD. (JP) | 1991-10-22 | — | — | US | disclosed |
| EP-0433024-A1 | Colour recording medium containing leuco dye | FUJI PHOTO FILM CO., LTD. (JP) | 1991-06-19 | — | — | EP | disclosed |
| EP-0346498-A1 | PROCESS FOR PROCESSING SILVER HALIDE COLOR PHOTOGRAPHIC MATERIALS | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140314702-A1 | COMPOSITION | IL17A, TRPA1, NR5A1 | KDM4E 1873/4885TDP1 3677/4885MAPK1 2896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.